The US private equity (PE) market in 2022 aligned overall with the broader M&A trend—activity eased off considerably, year-on-year, but remained above historic levels—and like the M&A market at large, it tailed off as the year progressed, but what does this mean for the year ahead?

M&A started strong in 2022 with robust deal activity and megadeals dominating the landscape that was largely the result of unprecedented spillover from 2021.

Despite a strong start to the year, deal activity in the US faced new challenges in 2022 as headwinds gathered.

White & Case Global Antitrust Merger StatPak (WAMS)

M&A Explorer | Private equity (PE) deal activity shrinks as buyer and vendor pricing expectations widen and rising interest rates drive significant tightening in acquisition finance markets

White & Case's Global Antitrust Merger StatPak (WAMS) is a resource providing information on merger control filing activity by competition authorities around the world. The WAMS survey currently includes filing data from 87 of the most active merger control jurisdictions in the world.

M&A Explorer | Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022

Geopolitical risks and inflationary pressures may have overtaken ESG as the top concerns for the mining & metals sector, but there is little expectation that ESG factors will diminish for investors and firms in 2023.

What importers need to know to comply with the US' growing arsenal of customs laws in the fight against forced labor